Journal
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Volume 18, Issue 11, Pages 3061-3066Publisher
WILEY
DOI: 10.1111/jth.15045
Keywords
purpura; thrombotic thrombocytopenic; ADAMTS13 protein; plasma exchange; caplacizumab; platelet count
Categories
Funding
- Else-Kroener-Fresenius Stiftung [2015_A224]
- SanofiGenzyme
- German Research Foundation [BR2955/8]
- Alexion
- Bayer
- Vifor
- Pfizer
- Ablynx/Sanofi
- Shire/Takeda
- CLS Behring
- Novo-Nordisk
- Roche
- Takeda
- Shire
Ask authors/readers for more resources
Background Acquired thrombotic thrombocytopenic purpura (aTTP) is a rare, life-threatening autoimmune thrombotic microangiopathy. Current standard of care is therapeutic plasma exchange, immunosuppression, and caplacizumab, an anti-von Willebrand factor nanobody, which is effective in treating aTTP episodes. Patients/Methods Here we report on seven episodes of aTTP treated without plasma exchange in six female patients in Germany and Austria. Two episodes were initial presentations of aTTP; in five instances, patients experienced a relapse. In four episodes, moderate to severe organ dysfunction was observed; three cases presented with a mild course. All patients received caplacizumab immediately once aTTP was suspected or diagnosed, and plasma exchange was omitted based on shared decision making between patient and the treating physicians. Results We observed a rapid and robust increase of platelet counts already after the first dose of caplacizumab, leading to a doubling of platelet counts within 17 hours (median), platelet counts normalized (>150 G/L) after median 84 hours. Lactate dehydrogenase, as a surrogate parameter of organ damage, improved in parallel to the platelet counts, indicating resolving microangiopathy. Conclusions In conclusion, in selected cases of acute bouts of aTTP, it seems feasible to delay or omit plasma exchange if platelet counts increase and organ function is stable after start of caplacizumab therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available